Published in Lancet on September 02, 1995
Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature (1987) 8.87
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (1998) 5.98
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol (2001) 4.34
Evolutionary history of a multigene family: an expressed human beta-tubulin gene and three processed pseudogenes. Cell (1983) 4.26
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Dynamic association of proteasomal machinery with the centrosome. J Cell Biol (1999) 3.30
Sequence of an expressed human beta-tubulin gene containing ten Alu family members. Nucleic Acids Res (1984) 3.08
The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell (1990) 2.73
Activation at M-phase of a protein kinase encoded by a starfish homologue of the cell cycle control gene cdc2+. Nature (1988) 2.71
Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques (1996) 2.60
Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis. Nature (2001) 2.19
Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol (1999) 2.09
Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem (2001) 2.08
Procyclic acidic repetitive protein (PARP) genes located in an unusually small alpha-amanitin-resistant transcription unit: PARP promoter activity assayed by transient DNA transfection of Trypanosoma brucei. Mol Cell Biol (1990) 2.01
Skin pigmentary anomalies and mosaicism for an acentric marker chromosome originating from 3q. J Med Genet (1999) 2.00
Five mouse tubulin isotypes and their regulated expression during development. J Cell Biol (1985) 1.85
Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature (1993) 1.85
A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol (2003) 1.73
[Erysipelas: epidemiological, clinical and therapeutic data (111 cases)]. Ann Dermatol Venereol (1991) 1.66
Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol (2001) 1.64
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology (1993) 1.64
VSG gene 118 is transcribed from a cotransposed pol I-like promoter. Cell (1987) 1.59
CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis. AJR Am J Roentgenol (1996) 1.59
Immuno and functional characterization of CFTR in submandibular and pancreatic acinar and duct cells. Am J Physiol (1997) 1.56
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) (2003) 1.55
Multiple functional P2X and P2Y receptors in the luminal and basolateral membranes of pancreatic duct cells. Am J Physiol (1999) 1.55
Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics (2000) 1.54
Recent trends of syphilis prevalence in normal population in Korea-1986. J Korean Med Sci (1988) 1.53
Inflammatory pseudotumor of the liver in patients with recurrent pyogenic cholangitis: CT-histopathologic correlation. Radiology (1999) 1.48
Evolutionary conservation of the human homologue of the yeast cell cycle control gene cdc2 and assignment of Cd2 to chromosome 10. Hum Genet (1988) 1.47
Radiologic findings of abdominal polyarteritis nodosa. AJR Am J Roentgenol (2000) 1.44
Hippocrates on necrotising fasciitis. Lancet (1994) 1.43
Hypochromic vitiligo: delineation of a new entity. Br J Dermatol (2014) 1.42
CT and MR imaging findings of bowel ischemia from various primary causes. Radiographics (2000) 1.40
[Apropos of recommendations concerning oral treatment of acne. An interview with the president S. Belaich. Interview by Hélne Allouch]. Presse Med (1999) 1.40
[Reasonable hospital use of mupirocin]. Ann Dermatol Venereol (2000) 1.40
Immunoscintigraphy in the detection of tuberculosis with radiolabelled antibody fragment against Mycobacterium bovis bacillus Calmette-Guérin: a preliminary study in a rabbit model. Eur J Nucl Med (1992) 1.39
Chromosome organization of the protozoan Trypanosoma brucei. Mol Cell Biol (1990) 1.38
Crystal structure of Escherichia coli CyaY protein reveals a previously unidentified fold for the evolutionarily conserved frataxin family. Proc Natl Acad Sci U S A (2000) 1.34
Cloning of the RNA2 gene of Saccharomyces cerevisiae. EMBO J (1984) 1.32
Constitutive activation of the Saccharomyces cerevisiae mating response pathway by a MAP kinase kinase from Candida albicans. Mol Gen Genet (1995) 1.32
Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol (2003) 1.32
Serologically diagnosed Lyme disease manifesting erythema migrans in Korea. J Korean Med Sci (1999) 1.32
A homolog of the cell cycle control protein p34cdc2 participates in the division cycle of Chlamydomonas, and a similar protein is detectable in higher plants and remote taxa. Plant Cell (1989) 1.30
Biliary ascariasis: MR cholangiography findings in two cases. Korean J Radiol (2001) 1.29
Antigenic variation in African trypanosomes. Trends Genet (1992) 1.26
RNA polymerase I-mediated protein-coding gene expression in Trypanosoma brucei. Parasitol Today (1992) 1.26
Differentiation of simple and strangulated small-bowel obstructions: usefulness of known CT criteria. Radiology (1997) 1.26
The procyclin repertoire of Trypanosoma brucei. Identification and structural characterization of the Glu-Pro-rich polypeptides. J Biol Chem (1999) 1.25
ERCP and CT findings of ectopic drainage of the common bile duct into the duodenal bulb. AJR Am J Roentgenol (1997) 1.25
Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res (2001) 1.23
Membrane-specific regulation of Cl- channels by purinergic receptors in rat submandibular gland acinar and duct cells. J Biol Chem (1997) 1.21
Intracellular localisation and expression of mammalian CDC2 protein during myogenic differentiation. Differentiation (1989) 1.20
Heterogeneity in the processing defect of SLC26A4 mutants. J Med Genet (2008) 1.20
Frequent independent duplicative transpositions activate a single VSG gene. Mol Cell Biol (1987) 1.19
Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events. Mol Cell Biol (1991) 1.19
Regulatory interaction between the cystic fibrosis transmembrane conductance regulator and HCO3- salvage mechanisms in model systems and the mouse pancreatic duct. J Biol Chem (2001) 1.19
Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol (1997) 1.16
1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis (2006) 1.16
Novel amiloride-sensitive sodium-dependent proton secretion in the mouse proximal convoluted tubule. J Clin Invest (2000) 1.16
The PARP and VSG genes of Trypanosoma brucei do not resemble RNA polymerase II transcription units in sensitivity to Sarkosyl in nuclear run-on assays. Nucleic Acids Res (1992) 1.15
Increased expression of cFLIP(L) in colonic adenocarcinoma. J Pathol (2001) 1.14
Gastrointestinal involvement in Henoch-Schönlein syndrome: CT findings. AJR Am J Roentgenol (1997) 1.12
Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein coupled receptor signalling. J Recept Signal Transduct Res (1999) 1.11
Association study of the g.8818A>G polymorphism of the human agouti gene with melanoma risk and pigmentary characteristics in a French population. J Dermatol Sci (2005) 1.11
Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet (2004) 1.10
Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J Pharmacokinet Biopharm (1993) 1.06
Therapeutic percutaneous aspiration of hepatic abscesses: effectiveness in 25 patients. AJR Am J Roentgenol (1993) 1.05
Upper gastrointestinal series and CT findings of primary gastric plasmacytoma: report of two cases. AJR Am J Roentgenol (1999) 1.03
Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm (1983) 1.03
Cloning of the mouse homologue of the yeast cell cycle control gene cdc2. DNA Seq (1990) 1.03
Xanthogranulomatous cholecystitis: radiologic findings with histologic correlation that focuses on intramural nodules. AJR Am J Roentgenol (1999) 1.02
Association between birth weight and insulin sensitivity in healthy young men in Korea: role of visceral adiposity. Diabetes Res Clin Pract (2000) 1.01
Disruption of largest subunit RNA polymerase II genes in Trypanosoma brucei. Mol Cell Biol (1993) 1.00
The gene family of EF-hand calcium-binding proteins from the flagellum of Trypanosoma brucei. Biochem J (1994) 1.00
Rapid detection of enterovirus in clinical specimens using PCR and microwell capture hybridization assay. J Virol Methods (1996) 1.00
HCO3- salvage mechanisms in the submandibular gland acinar and duct cells. J Biol Chem (2001) 1.00
Insights into eukaryotic multistep phosphorelay signal transduction revealed by the crystal structure of Ypd1p from Saccharomyces cerevisiae. J Mol Biol (1999) 0.99
Radionuclide therapy of skin cancers and Bowen's disease using a specially designed skin patch. J Nucl Med (1997) 0.99
Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol (1997) 0.98
Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus. Br J Pharmacol (1997) 0.98
US findings of xanthogranulomatous cholecystitis. Clin Radiol (1998) 0.98
Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes (2000) 0.98
Receptor-mediated endocytosis in the procyclic form of Trypanosoma brucei. J Biol Chem (2000) 0.97
PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer (2006) 0.97
Loculated fluid collections in hepatic fissures and recesses: CT appearance and potential pitfalls. Radiographics (1994) 0.96
Recurrent erysipelas: 47 cases. Dermatology (2007) 0.96
Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. Br J Pharmacol (2006) 0.96
Icodextrin cutaneous hypersensitivity: report of 3 psoriasiform cases. Arch Dermatol (2001) 0.96
Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm Drug Dispos (1987) 0.96
Usefulness of CT in patients with ischemic colitis proximal to colonic cancer. AJR Am J Roentgenol (1997) 0.95
[Prognostic factors and predictive signs of malignancy in adult dermatomyositis]. Ann Dermatol Venereol (1996) 0.93
Domestic and school violence among high school students in Jamaica. West Indian Med J (2000) 0.93
Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2. Br J Pharmacol (2010) 0.93
Inducible DNA repair in Ustilago maydis. Mol Gen Genet (1982) 0.93
LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Gene Ther (1996) 0.93